Pharmabiz8m
Chugai to transfer future marketing of secondary hyperparathyroidism drug “Oxarol for injection” in Japan to LTL Pharma
Chugai to transfer future marketing of secondary hyperparathyroidism drug “Oxarol for injection” in Japan to LTL Pharma: Tokyo Thursday, August 29, 2024, 14:00 Hrs [IST] Chuga ...
Pharmabiz1h
Neurocrine Biosciences announces positive results from phase 2 study of NBI-1117568 in adults with Schizophrenia
Neurocrine Biosciences announces positive results from phase 2 study of NBI-1117568 in adults with Schizophrenia: San Diego Thursday, August 29, 2024, 13:00 Hrs [IST] Neurocrine B ...
Pharmabiz2h
Biocon Biologics secures market entry for Bmab 1200, a proposed biosimilar to Stelara, in Europe, UK, Canada & Japan
Biocon Biologics secures market entry for Bmab 1200, a proposed biosimilar to Stelara, in Europe, UK, Canada & Japan: Our Bureau, Bengaluru Thursday, August 29, 2024, 11:45 Hrs [I ...
Pharmabiz1h
Cambrian Bioworks raises $1.45 million in seed funding to transform molecular diagnostics in India
Cambrian Bioworks raises $1.45 million in seed funding to transform molecular diagnostics in India: Our Bureau, Bengaluru Thursday, August 29, 2024, 12:15 Hrs [IST] Cambrian Biowo ...
Pharmabiz2h
‘Low-intensity’ blood stem cell transplants for sickle cell appear safe for lung health: NIH study
Bethesda, Maryland Thursday, August 29, 2024, 12:00 Hrs [IST] ...
Pharmabiz3h
Chugai announces Japanese MHLW approves additional indication of Alecensa for adjuvant treatment for people with ALK-positive early-stage NSCLC
Chugai Pharmaceutical Co., Ltd. announced that the Ministry of Health, Labour and Welfare (MHLW) has approved the additional indication of Alecensa (alectinib), a Chugai originated antineoplastic ...
Pharmabiz5h
GSK receives Japanese MHLW approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps
GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), for the treatment of chronic ...
Pharmabiz6h
Dietary supplement market undergoes a shift driven by natural, organic, vegan & GI-tagged brands: Sanjaya Mariwala
India’s dietary supplements market is undergoing a shift driven by natural, organic, vegan, cruelty-free, and GI-tagged brands, said Sanjaya Mariwala, executive chairman and managing director, ...
Pharmabiz6h
Second Siddha medical college out of TN likely to come in Telangana, one SMHSU to be opened in Hyderabad soon
Telangana government is likely to start one Siddha Medical Health Services Unit (SMHSU), a medical unit in the status of a PHC, in Hyderabad as a preliminary step to establish one Siddha medical ...
Pharmabiz6h
Methylcobalamin proven effective for diabetic neuropathy, but regulatory delay stalls official ban lift
Despite scientific evidence supporting the efficacy of methylcobalamin, particularly in the treatment of diabetic neuropathy, the Union ministry of health’s lifting of the ban on this essential ...
Pharmabiz6h
Tech roles to lead employment growth in healthcare sector: Expert
With a spike in the technology-related roles in the sector, mainly the application of artificial intelligence (AI) and machine learning (ML), the healthcare industry is poised to see a hike of 15-20 ...
Pharmabiz6h
NCISM mandates Aadhar enabled biometric attendance system in Ayurveda, Unani colleges
The National Commission for Indian System of Medicine (NCISM) has amended the NCISM regulations to mandate an Aadhar enabled biometric attendance system for the staff and post graduate students ...